OBJECTIVE: To investigate the in vivo activity of poly(sodium 4-styrene sulfonate) (T-PSS) gel formulations as topical microbicides. METHODS: The ability of the gel formulations to reduce the incidence of infection when applied prior to pathogen challenge was examined in mouse models of vaginal herpes simplex type 2 (HSV-2) and Chlamydia trachomatis infection, and rectal HSV-2 infection. RESULTS: In the vaginal HSV-2 challenge studies, 10% T-PSS gel provided significant protection against infection, even when administered 60 min prior to virus challenge (P < 0.0001). Both 5% and 10% T-PSS gel formulations significantly reduced the incidence of upper genital tract C. trachomatis infection in animals treated up to 5 min before challenge (P < 0.001). However, no protection against C. trachomatis infection was seen in animals treated 30 min before challenge. In mice challenged rectally with HSV-2, both the 5% and 10% T-PSS gels significantly reduced infection at 20 s (P < 0.01 for both). However, only the 10% gel provided significant protection when administered 5 min before challenge (P < 0.01). CONCLUSIONS: T-PSS gel formulations have promising in vivo activity as topical microbicides.
OBJECTIVE: To investigate the in vivo activity of poly(sodium 4-styrene sulfonate) (T-PSS) gel formulations as topical microbicides. METHODS: The ability of the gel formulations to reduce the incidence of infection when applied prior to pathogen challenge was examined in mouse models of vaginal herpes simplex type 2 (HSV-2) and Chlamydia trachomatis infection, and rectal HSV-2 infection. RESULTS: In the vaginal HSV-2 challenge studies, 10% T-PSS gel provided significant protection against infection, even when administered 60 min prior to virus challenge (P < 0.0001). Both 5% and 10% T-PSS gel formulations significantly reduced the incidence of upper genital tract C. trachomatis infection in animals treated up to 5 min before challenge (P < 0.001). However, no protection against C. trachomatis infection was seen in animals treated 30 min before challenge. In mice challenged rectally with HSV-2, both the 5% and 10% T-PSS gels significantly reduced infection at 20 s (P < 0.01 for both). However, only the 10% gel provided significant protection when administered 5 min before challenge (P < 0.01). CONCLUSIONS:T-PSS gel formulations have promising in vivo activity as topical microbicides.
Authors: Valence M K Ndesendo; Viness Pillay; Yahya E Choonara; Lisa C du Toit; Eckhart Buchmann; Leith C R Meyer; Riaz A Khan; Uwe Rosin Journal: AAPS PharmSciTech Date: 2010-05-06 Impact factor: 3.246
Authors: Christine K Mauck; Debra H Weiner; Susan A Ballagh; Mitchell D Creinin; David F Archer; Jill L Schwartz; Helen C Pymar; Jaim-Jou Lai; William F Rencher; Marianne M Callahan Journal: Contraception Date: 2004-07 Impact factor: 3.375
Authors: Craig R Cohen; Joelle Brown; Anna-Barbara Moscicki; Elizabeth A Bukusi; Jeremy R A Paull; Clare F Price; Stephen Shiboski Journal: PLoS One Date: 2011-01-20 Impact factor: 3.240
Authors: Karen M Gallegos; Christopher R Taylor; Daniel J Rabulinski; Rosalinda Del Toro; Danielle E Girgis; Dapinder Jourha; Vaibhav Tiwari; Umesh R Desai; Kyle H Ramsey Journal: Front Microbiol Date: 2019-01-16 Impact factor: 5.640